MedPath

Exploring Acceptance and Outcomes of an Online-based Self-management Support System in Chronic Illness

Not Applicable
Conditions
Chronic Heart Failure
Special Orthopaedic Co-Morbidity After Hip/Knee Replacement
Chronic Obstructive Pulmonary Disease
Diabetes Mellitus
Interventions
Device: SENACA - ICT based self-management support system
Registration Number
NCT02832739
Lead Sponsor
Assuta Medical Center
Brief Summary

The aim of the USECARE project is to improve and test SENACA, an ICT-based self-management support system for chronically ill patients and informal caregivers. 60 end-users will be instructed to use SENACA for approx. 3 months (in Israel and Norway). Amongst others, clinical and behavioural outcomes will be recorded. Additionally, SENACA's usability will be evaluated to determine its potential future scalability.

Detailed Description

In Switzerland, SENior health ACAdemy (SENACA, www.senaca.ch) has been developed by the European Medical Network EMN.

SENACA is a structured self-management support system with several interacting components, combining tele-monitoring devices and a solution for personalised health plans. This online support system's usability, the behaviour change techniques it builds on, modes of delivery and its effects on health-related behaviour, clinical and Quality-of-Life outcomes will be established in a larger group of end-users.

Testing the usability of SENACA and practical effectiveness of this intervention is the goal of this multi-national project USECARE (www.usecare.eu).

SENACA will be implemented in two countries (Israel and Norway ) via field test with community-dwelling older adults living with chronic conditions (i.e. diabetes, COPD, chronic heart failure) and their informal caregivers.

Key element of USECARE is a field-test including a study based upon pre-experimental design with three time point measurements and a pre-usability round. Multiple methods will be used to evaluate the usability and to observe clinical and process parameters before, during and after the implementation of the enhanced SENACA prototype.

All of the results combined will provide an insight into the end-user experience, usage pattern, usability perception and potential added value of the enhanced SENACA prototype for chronic disease management in the participating countries.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SENACA - self-management support systemSENACA - ICT based self-management support systemUse of enhanced SENACA - ICT based self-management support system prototype by study participants at home for 75-100 days
Primary Outcome Measures
NameTimeMethod
Level of and potential changes in technology acceptance in participantsUp to three months

Technology acceptance (usability) of system is measured by assessing participants' intention to use, perceived ease of use, perceived usefulness, technology experience, preference in using technology, errors, and user satisfaction. Instruments used are: Technology Acceptance Model (TAM), Post-Study System Usability Questionnaire (PSSUQ), all self-reported questionnaires. In addition, system errors will be reported (number and type of problems).

Secondary Outcome Measures
NameTimeMethod
Level of and potential changes in health-related quality of life of participants assessed by EQ5D5LUp to three months

Use of EQ-5DL a standardised instrument to measure health outcome and health-related quality of life.

Level of and potential changes in self-efficacy of participantsUp to three months

Measured with the Stanford Self-efficacy for managing chronic disease scale (SES6)

Level of and potential changes in health-related behaviour: nutrition & alcohol consumption, smoking, physical activityUp to three months

Self-reported questionnaires on weekly unit consumption (nutrition/alcohol), exercise (in Norway) and walking (minutes or hours/week), smoking behaviour (tobacco products, consumption per day), alcohol (units/week).Physical activity will be recorded automatically via pedometer (device).

Level of and potential changes in uptake and usage of the SENACA intervention by participantsUp to three months

Automated recording of relative frequency of usage of SENACA's modules (usage of single components that are not mandatory), adherence to SENACA (Number of days within program from initiation to discontinuation (time to event), errors of system during intervention (number and type of technical problems occurring)

Level of and potential changes in eHealth Literacy in participantsUp to three months

eHealth Literacy is defined as the ability to read, use computers, search for information, understand health information, and put it into context.The eHealth Literacy Scale (eHEALS) as an 8-item measure will be used (self-reported questionnaire).

Level of and potential changes in selected clinical outcomes of participants : BMI, weight, fasting glucose as well as HbA1c levels (sample)Up to three months

Changes in selected clinical outcomes will be assessed with automated measurements via the intervention devices concerning body fat (fat proportion of body in %), body weight (in kg), blood pressure (systolic/diastolic in mmHg), pulse (per minute), SpO2 (in %) and fasting glucose (mmol). In Norway sample laboratory test will be conducted to determine levels of cholesterols (HDL, LDL in mmol), triglyceride (in mmol), HbA1c (mmol) and BNP (pg/ml).

Trial Locations

Locations (2)

Assuta Medical Center

🇮🇱

Tel Aviv, Israel

University Hospital North Norway

🇳🇴

Tromsoe, Norway

© Copyright 2025. All Rights Reserved by MedPath